Figure 6From: Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysemaEffects of long-term augmentation therapy with alpha-1 antitrypsin in an MZ-AAT severe persistent asthma. Forced Expiratory Volume (A), Alpha-1-antitrypsin (AAT) serum concentrations (B), and Asthma Quality of Life (C) scores after and before alpha-1-antitrypsin infusions.Back to article page